Brought to you by 
NEA leads $77.5mm private financing for Ardelyx
04 Jun 2015
Executive Summary
Existing shareholder New Enterprise Associates led a $77.5mm financing in Ardelyx Inc. (small-molecule treatments for cardio-renal, GI, and metabolic diseases), which sold 7.2mm shares for $10.70 (a 2% discount). Investors received warrants to buy 2.2mm shares at $13.91. The placement agent was Leerink Partners.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Private Investment in Public Equity
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
NEA leads $77.5mm private financing for Ardelyx
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice